189 related articles for article (PubMed ID: 7834452)
1. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer.
Cody HS; Urban JA
Ann Surg Oncol; 1995 Jan; 2(1):32-7. PubMed ID: 7834452
[TBL] [Abstract][Full Text] [Related]
2. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.
Fowble B; Hanlon A; Freedman G; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Torosian M; Goldstein L
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):883-94. PubMed ID: 10863056
[TBL] [Abstract][Full Text] [Related]
3. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
[TBL] [Abstract][Full Text] [Related]
4. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.
Avril A; Le Bouëdec G; Lorimier G; Classe JM; Tunon-de-Lara C; Giard S; MacGrogan G; Debled M; Mathoulin-Pélissier S; Mauriac L;
Eur J Surg Oncol; 2011 Jul; 37(7):563-70. PubMed ID: 21665421
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
6. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
8. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
[TBL] [Abstract][Full Text] [Related]
9. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
10. Prognostic analysis of survival in small breast cancers.
Mustafa IA; Cole B; Wanebo HJ; Bland KI; Chang HR
J Am Coll Surg; 1998 May; 186(5):562-9. PubMed ID: 9583697
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy.
Noh JM; Kim KH; Park W; Suh CO; Huh SJ; Choi DH; Keum KC; Kim YB
Breast; 2015 Oct; 24(5):637-41. PubMed ID: 26283599
[TBL] [Abstract][Full Text] [Related]
12. Implications of Internal Mammary Lymph Node Sampling During Microsurgical Breast Reconstruction.
Rose JF; Zavlin D; Menn ZK; Eldor L; Chegireddy V; Baker TP; Teh BS; Lim SJ; Spiegel AJ
Ann Surg Oncol; 2018 Oct; 25(11):3134-3140. PubMed ID: 30051362
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
14. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
15. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
16. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?
Freedman GM; Fowble BL; Nicolaou N; Sigurdson ER; Torosian MH; Boraas MC; Hoffman JP
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):805-14. PubMed ID: 10705000
[TBL] [Abstract][Full Text] [Related]
17. Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14).
Kim K; Kim SS; Shin KH; Kim JH; Ahn SD; Choi DH; Park W; Lee SY; Chun M; Kim JH; Kim YB; Cha J; Park HJ; Lee DS; Jung W
Clin Breast Cancer; 2020 Feb; 20(1):51-60. PubMed ID: 31629642
[TBL] [Abstract][Full Text] [Related]
18. Should internal mammary nodes be sampled in the sentinel lymph node era?
Sugg SL; Ferguson DJ; Posner MC; Heimann R
Ann Surg Oncol; 2000 Apr; 7(3):188-92. PubMed ID: 10791848
[TBL] [Abstract][Full Text] [Related]
19. Opportunistic Biopsy of Internal Mammary Lymph Nodes During Immediate Breast Reconstruction After Mastectomy for Breast Malignancies.
Hong KY; Lee HB; Yim S; Lee J; Kim TY; Han W; Jin US
Ann Surg Oncol; 2017 Jul; 24(7):1881-1888. PubMed ID: 28332035
[TBL] [Abstract][Full Text] [Related]
20. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
